Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CASP1 | P29466 | 4/20 | 0.45 |
| ▸ | TSHR | P16473 | 2/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.41 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 6/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | RECQL | P46063 | 3/20 | 0.39 |
| ▸ | POLB | P06746 | 2/20 | 0.39 |
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
| ▸ | NPC1 | O15118 | 1/20 | 0.39 |
| ▸ | MITF | O75030 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.37 |
| ▸ | MEN1 | O00255 | 2/20 | 0.37 |
| ▸ | THRB | P10828 | 2/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18147661 | 0.83 | CASP1 (0.44) | CASP1TSHRALDH1A1CYP3A4PDE10A | |
| SCHEMBL11290855 | 0.79 | TSHR (0.40) | CASP1TSHRALDH1A1CYP3A4PDE10A | |
| SCHEMBL2851972 | 0.77 | MAPT (0.37) | CASP1ALDH1A1CYP3A4MAPTCYP2C9 | |
| SCHEMBL10492390 | 0.76 | CYP1B1 (0.48) | ALDH1A1L3MBTL1MAPTCYP2C9CYP1A2 | |
| SCHEMBL10492388 | 0.76 | CYP1B1 (0.48) | ALDH1A1L3MBTL1MAPTCYP2C9CYP1A2 | |
| SCHEMBL11287375 | 0.75 | CASP1 (0.37) | CASP1TSHRALDH1A1CYP3A4PDE10A | |
| SCHEMBL18509676 | 0.74 | ALDH1A1 (0.50) | CASP1TSHRALDH1A1CYP3A4PDE10A | |
| SCHEMBL865227 | 0.73 | ALDH1A1 (0.54) | CASP1TSHRALDH1A1CYP3A4PDE10A | |
| SCHEMBL1018391 | 0.72 | PDE10A (0.44) | CASP1TSHRALDH1A1CYP3A4PDE10A | |
| SCHEMBL4013274 | 0.72 | CASP1 (0.40) | CASP1TSHRALDH1A1CYP3A4PDE10A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4131548-B1 | NON-AQUEOUS ELECTROLYTE FOR BATTERY, PRECURSOR FOR LITHIUM SECONDARY BATTERY, METHOD FOR MANUFACTURING LITHIUM SECONDARY BATTERY, LITHIUM SECONDARY BATTERY, PHOSPHAZENE COMPOUND, AND ADDITIVE FOR BATTERY | MITSUI CHEMICALS INC (JP) | 2025-08-27 | — | — | EP | disclosed |
| US-20230110251-A1 | NON-AQUEOUS ELECTROLYTE FOR BATTERY, PRECURSOR FOR LITHIUM SECONDARY BATTERY, METHOD FOR MANUFACTURING LITHIUM SECONDARY BATTERY, LITHIUM SECONDARY BATTERY, PHOSPHAZENE COMPOUND, AND ADDITIVE FOR BATTERY | MITSUI CHEMICALS, INC. (JP) | 2023-04-13 | — | — | US | disclosed |
| EP-0950679-B1 | Process for preparing poly(alkylene oxide) | MITSUI CHEMICALS INC (JP) | 2004-11-17 | — | — | EP | disclosed |
| EP-0950679-A2 | Process for preparing poly(alkylene oxide) | Mitsui Chemicals, Inc. (JP) | 1999-10-20 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230110251-A1 | NON-AQUEOUS ELECTROLYTE FOR BATTERY, PRECURSOR FOR LITHIUM SECONDARY BATTERY, METHOD FOR MANUFACTURING LITHIUM SECONDARY BATTERY, LITHIUM SECONDARY BATTERY, PHOSPHAZENE COMPOUND, AND ADDITIVE FOR BATTERY | PHOSPHO1, SLC9B2, SLC9A2 | CASP1 2231/4885TSHR 732/4885ALDH1A1 3982/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.